2023 journal article

Evaluation of thrombin generation in dogs administered clopidogrel

FRONTIERS IN VETERINARY SCIENCE, 10.

By: K. Rank n, A. Lynch n, L. Ruterbories n, R. Li n & Y. Ueda n

author keywords: coagulation; platelet inhibitory; antithrombotic; therapeutic monitoring; canine
TL;DR: Thrombin generation performed on platelet poor plasma may not be a useful antiplatelet monitoring tool in dogs, despite concomitant changes in TEG-PM variables consistent with platelet inhibition. (via Semantic Scholar)
UN Sustainable Development Goal Categories
1. No Poverty (OpenAlex)
Source: Web Of Science
Added: September 11, 2023

IntroductionThe antiplatelet effect of clopidogrel can vary between patients. A modified thromboelastography (TEG) protocol (TEG-Platelet Mapping assay® [TEG-PM]) can be used for clopidogrel monitoring but is not widely available. Thrombin generation (TG) assays could offer a novel alternative. The main objective of this pilot study was to assess TG assay variables (lag time, peak, endogenous thrombin potential [ETP]) in dogs before and after 7 days of clopidogrel administration and compare with TEG-PM variables (maximum amplitude [MA]-ADP and percentage (%) inhibition).